Accéder directement au contenu
MB

Marc Boudvillain

7
Documents
Identifiants chercheurs

Présentation

- **CNRS Research director** and group Leader at CBM - **Deputy director** of CBM since January 2018. Education --------- - **PhD Thesis** in Biochemistry and Molecular Biophysics, University of Orléans (1996). - **Master of Science** (specialty: Biological Chemistry) from the Universities of Orléans, Paris Descartes, and Paris Sud (joint program, 1992). Professional experience ----------------------- - **Tenured Scientist** at CNRS, CBM since October 1999. Biochemistry of RNA and RNA-protein complexes; Regulation of bacterial transcription; RNA helicase mechanisms - **Postdoctoral Research Scientist** at Columbia University and Howard Hugues Medical Institute (New York, USA). Biochemistry of RNA; Structure, function and catalysis by group II intron ribozymes (1996-1999). - **Graduate Research Scientist** at CBM. Nucleic acid Biochemistry; Inorganic chemistry; Engineering of synthetic Pt(II)-based metalloribozymes (1993-1996).

Publications

rozenn-dalbies-tran

Trans-Diamminedichloroplatinum (II) Is Not an Antitumor Drug: Why?

Marc Boudvillain , Rozenn Dalbies-Tran , Leng M.
Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy, 2, Plenum Press, New'Tork, USA, pp.17-25, 1996
Chapitre d'ouvrage hal-02097755v1